SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001636050-21-000004
Filing Date
2021-01-04
Accepted
2021-01-04 08:01:25
Documents
16
Period of Report
2021-01-04
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K siox-20210104.htm   iXBRL 8-K 44068
2 EX-99.1 siox8-kexx991_010421.htm EX-99.1 10985
8 GRAPHIC siox2.gif GRAPHIC 47340
  Complete submission text file 0001636050-21-000004.txt   280289

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20210104.xsd EX-101.SCH 2418
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT siox-20210104_cal.xml EX-101.CAL 710
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20210104_def.xml EX-101.DEF 1647
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20210104_lab.xml EX-101.LAB 27194
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20210104_pre.xml EX-101.PRE 14239
9 EXTRACTED XBRL INSTANCE DOCUMENT siox-20210104_htm.xml XML 12639
Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 21500228
SIC: 2834 Pharmaceutical Preparations